Cargando…

360. The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis

BACKGROUND: Chronic disseminated candidiasis (CDC) is a specific syndrome in patients with hematologic malignancies which usually occurs after the recovery of neutrophils due to previous chemotherapy. The beta-D-glucan (BDG) assay has been proposed as an adjunct test for diagnosing invasive fungal i...

Descripción completa

Detalles Bibliográficos
Autor principal:	Son, Hyo-Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752370/ http://dx.doi.org/10.1093/ofid/ofac492.438

Ejemplares similares

Experience with β-d-Glucan Assay for Diagnosis of Invasive Candidiasis in ICU Patients: Pilot Study from India
por: Bansal, Nitin, et al.
Publicado: (2017)

Diagnostic performance of the (1–3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers
por: Son, Hyo-Ju, et al.
Publicado: (2017)

1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
por: Whitehurst, Daniel, et al.
Publicado: (2023)

β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model
por: Khodadadi, Hossein, et al.
Publicado: (2014)

Utility of Serial β-d-Glucan Levels in Patients with High Risk for Invasive Candidiasis: A Potential Tool for Antifungal Stewardship
por: Chua, Alvin Qijia, et al.
Publicado: (2017)

Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study
por: Bansal, Nitin, et al.
Publicado: (2018)

Experience of using beta-D-glucan assays in the intensive care unit
por: Dagens, A., et al.
Publicado: (2018)

Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis
por: Murri, Rita, et al.
Publicado: (2021)

Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study)
por: Ramos, Jose Tomas, et al.
Publicado: (2017)

Health from grain: oat beta-glucan
por: Martin Marais, Lovisa
Publicado: (2017)

The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis
por: Guo, Junfei, et al.
Publicado: (2019)

Beta-D-Glucan in Patients with Haematological Malignancies
por: Mikulska, Malgorzata, et al.
Publicado: (2021)

1701. Trends in Invasive Candidiasis in Children with Hematologic Malignancies: Increased Risk of Dissemination with Non-albicans Candida
por: Said, Amira, et al.
Publicado: (2023)

Reply to the letter to the editor “chronic disseminated candidiasis” by Kenneth Rolston
por: Della Pepa, Roberta, et al.
Publicado: (2017)

A case of chronic disseminated candidiasis in metamizole-induced neutropaenia
por: Colin-Benoit, Eugénie, et al.
Publicado: (2022)

2044. Utility of Serum Β-D Glucan Assay for Diagnosis of Invasive Fungal Infections in Solid Organ Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2018)

In vitro models of hematogenously disseminated candidiasis
por: Filler, Scott G
Publicado: (2014)

1468 Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis
por: Rhein, Joshua, et al.
Publicado: (2014)

Effects of beta-glucan in a mice model of vaginitis by candida albicans
por: De Farias Sales, Valéria Soraya, et al.
Publicado: (2015)

1701. Differences in Diagnostic Performance of β-d-Glucan Testing in Patients with Varying Degrees of Susceptibility to Invasive Fungal Infections
por: Nham, Eliel, et al.
Publicado: (2019)

250. Comparison of T2Candida Assay with Blood Culture, Candida Sepsis Score and Serum β-d-glucan in Diagnosis of Candidemia
por: Nizami, Sobia, et al.
Publicado: (2019)

Case for diagnosis. Disseminated erythematous and scaly plaques: chronic mucocutaneous candidiasis()
por: Abreu, Nathalia Chebli de, et al.
Publicado: (2023)

Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2019)

934. Diagnostic Utility of Blood (1- >3)-β-D-Glucan Testing in Patients with HIV in Arkansas
por: Krishnan, Gayathri, et al.
Publicado: (2020)

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis
por: Wring, Stephen A., et al.
Publicado: (2017)

418. Evaluation of β-d-Glucan (BG) and Galactomannan (GM) Detection Assays in the Diagnosis of Invasive Fungal Infections in High-Risk Pediatric Cancer Patients
por: Alali, Muayad, et al.
Publicado: (2018)

93. A Diagnostic Stewardship Intervention to Improve Utilization of 1,3-β-D-glucan Testing
por: Kendall, Jonathan A, et al.
Publicado: (2020)

115. The Utility of (1→3)-β-D-glucan Assay in the Diagnosis of Severe Coccidioidomycosis Infections among Immunocompromised Hosts
por: Ayazi, Parham, et al.
Publicado: (2021)

Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study
por: Novy, Emmanuel, et al.
Publicado: (2023)

Evaluation of the Efficacy of CD101, a Novel Echinocandin, in the Treatment of Candida auris Infection Using a Murine Model of Disseminated Candidiasis
por: Hager, Christopher, et al.
Publicado: (2017)

1173. Ocular Candidiasis in Patients with Candidemia Diagnosed by Blood Culture Versus T2Candida® Assay
por: White, Cameron, et al.
Publicado: (2020)

Breakthrough Invasive Candidiasis in Children
por: Dong, Sara, et al.
Publicado: (2017)

316. Use of (1-3)-β-D-Glucan Assay for Diagnosis of Candidemia in Patients Hospitalized with SARS-CoV-2 Infection
por: Malik, Yesha, et al.
Publicado: (2021)

Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?
por: Eggimann, Philippe, et al.
Publicado: (2011)

(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Diagnostic Performance of Bronchoalveolar Lavage (1,3)-β-d-Glucan Assay for Pneumocystis jirovecii Pneumonia
por: Zhou, Shiwei, et al.
Publicado: (2020)

P023 Evaluation of Beta-D-glucan assay as a tool for antifungal stewardship at a hospital in Mumbai, India
por: Thakkar, Pooja, et al.
Publicado: (2022)

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
por: Hanson, Kimberly E., et al.
Publicado: (2012)

Disseminated candidiasis 18 years after renal transplantation
por: Bismay, K., et al.
Publicado: (2012)

Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis
por: Myint, Thein, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_91hb4ap4cg3q3c894lkrmqg1lr